BioPharma Manufacturing in Massachusetts: A Talent Powerhouse Continues to Fuel Growth

December 8, 2020 10:00 AM - 11:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 12/8/2020 10:00:00 AM 12/8/2020 11:00:00 AM BioPharma Manufacturing in Massachusetts: A Talent Powerhouse Continues to Fuel Growth

Massachusetts has long been the epicenter of biopharma research and development. Years of investment and collaboration between industry, academia, and government has provided biopharma manufacturers a rich and deep talent landscape in Massachusetts. Join leaders in the biopharma industry and higher education as they discuss current talent development assets, share initiatives to grow talent even further, and look to the future as the industry continues its growth in Massachusetts.

This virtual Forum, hosted in partnership by MassBio, MassECON, MassBioEd, and the Massachusetts Life Sciences Center, will include an overview of current biopharma talent assets and how the pool of talent has grown in recent years, followed by an industry-higher education panel that will share case studies on collaboration and insights on what is on the horizon for new talent development.

Please learn more about our higher education panelists and their programs here: 


Here is the agenda for the event:
  • Welcome from Bob Coughlin – 2 minutes
  • Overview / State of Biomanufacturing in MA from Ryan Mudawar, MLSC – 6-8 minutes
  • Moderated panel & Q&A – 40 minutes
  • Wrap-up – 2-5 minutes
 

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view
Vice President/General Manager, Thermo Fisher Scientific
Christopher Murphy is Vice President and General Manager of Viral Vector Services in Thermo Fisher Scientific’s Pharma Services Group. Prior to joining Thermo Fisher, Chris served as chief operating officer for Brammer Bio, a leading viral vector/gene therapy CDMO. Chris has more than 30 years of experience in biopharmaceutical manufacturing, process development, plant operations, and quality system implementation. Prior to joining Brammer Bio, Chris served as general manager for the Sanofi-Genzyme Allston Landing site overseeing operations and leading an integrated remediation program associated with the consent decree. Chris has led gene therapy operations and recombinant protein manufacturing at Genzyme and Bioreliance and he began his career in viral vaccine development at American Cyanamid/Wyeth (now Pfizer) in Pearl River, NY. He has an M.Sc. in biochemistry at New York Medical College, and his B.Sc. in biology at Rutgers University.

Brought to you by